News Archive

A new degree program developed jointly by UMBC and Montgomery College (MC), and soon to be offered at The Universities at Shady Grove (USG), will create opportunities for students of all backgrounds to pursue high-demand careers in the life sciences. The four-year Translational Life Science Technology (TLST) program, which leads to a bachelor of science degree from UMBC, will train students in the fundamentals of biochemistry, cell biology, epidemiology, statistics, lab instrumentation, and biochemical engineering, as well as give students opportunities to develop sought-after skills such as analytical thinking, teamwork, and data evaluation. The TLST program is accepting students now, and courses will begin in fall 2018.

Machfu, an Industrial Internet of Things (IIoT) technology company, announced today the release of its MACH-3 IIoT Gateway, a device allowing companies in energy, water, oil and gas as well as other industrial segments to seamlessly connect legacy infrastructure to cloud based IoT and existing SCADA systems. The product was designed to both simplify the connection and management of devices as well as provide a secure and easily customizable application framework to process and manage data at the network edge. The versatile functionalities of the MACH-3 IIoT Gateway will be demonstrated at the 2018 DistribuTECH show, January 22-25 in San Antonio, Texas.

The entire continental U.S. is experiencing widespread flu right now, the first time in the 13 years of the current tracking system that that has happened, according to the CDC.

It’s another year, and the annual J.P. Morgan Healthcare Conference, along with all the small and big events it has spawned, has concluded. San Franciscans have their city back from the money-seeking health entrepreneurs, the CEOs, their retinue, and the investor hordes.

Venture capitalists poured $1.55 billion into D.C. area technology start-ups last year, an industry report found, as a handful of so-called megadeals propelled the region to a six-year high for technology investing in 2017.

US ANNUAL FUNDING TOPS $70B FOR SECOND TIME

2017 was the second year that saw dollar funding top $70B, but deals declined for the third straight year, falling 4% from 2016 and reaching the lowest annual total since 2012.

2018 is already seeing big deals in the cancer therapy space with Celgene’s recent buyout of Impact Biomedicines, which develops a key drug for treating complex cancers.

Other big pharma names like Pfizer, Novartis, and GlaxoSmithKline have also been active in the last 5 years with key investments to cancer startups as they make bets to avoid missing out on strengthening their cancer drug pipelines.

To state the obvious: Drugs are increasingly complex and so are their patent lives.

More than 110 companies have graduated since bwtech@UMBC began offering incubation services in 1989.

Cell therapy is the delivery of living cells to treat, or potentially cure, a person’s disease. The transplantation of hematopoietic stem cells from a donor to a recipient to create bone marrow, for instance, is one well-established form of cell therapy.